Pro-Pe

Developed for: aphthous stomatitis
Investigated by: Grant from "Axiomedic. Advanced Medical Solutions", Zurich, Switzerland · Hadassah Medical Organization

today NCT00281723 · Ph 2

200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 2	NCT00281723	? → May 2007	aphthous stomatitis	Hadassah Medical Organization	Suspended	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Pro-Pe	ClinicalTrials.gov intervention name — accepted as the source's own label NCT00281723 ↗
Route	Oral	“apply the oral-tablet” NCT00281723 ↗